Mast Cell Stabilization Alleviates Acute Lung Injury after Orthotopic Autologous Liver Transplantation in Rats by Downregulating Inflammation

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Zhang, Ailan ^a   Chi, Xinjin ^a   Luo, Gangjian ^a   Hei, Ziqing ^a   Xia, Hua ^b   Luo, Chenfang ^a   Wang, Yanling ^a   Mao, Xiaowen ^c   Xia, Zhengyuan ^c  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE A; CROMOGLYCATE DISODIUM; INTERLEUKIN 1BETA; INTERLEUKIN 6; KETOTIFEN; SURFACTANT PROTEIN C; TRANSCRIPTION FACTOR RELA; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL BLOOD; ARTICLE; BLOOD OXYGEN TENSION; CELL ACTIVATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER TRANSPLANTATION; LUNG PARENCHYMA; MALE; MAST CELL; MAST CELL DEGRANULATION; MAST CELL STABILIZATION; NONHUMAN; PROCEDURES CONCERNING CELLS; RAT; SPRAGUE DAWLEY RAT; UPREGULATION; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANIMALS; CROMOLYN SODIUM; DISEASE MODELS, ANIMAL; DOWN-REGULATION; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; KETOTIFEN; LIVER TRANSPLANTATION; MALE; MAST CELLS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885111670     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075262     Document Type: Article

References (60)

1. Mueller AR, Platz KP, Kremer B, (2004) Early postoperative complications following liver transplantation. Best Pract Res Clin Gastroenterol 18: 881-900.
2. Yost CS, Matthay MA, Gropper MA, (2001) Etiology of acute pulmonary edema during liver transplantation: a series of cases with analysis of the edema fluid. Chest 119: 219-223.
3. Li SR, Shen N, Hei ZQ, (2008) [Early risk factors of acute lung injury following orthotopic liver transplantation]. Zhonghua Yi Xue Za Zhi 88: 3049-3052.
4. Guo N, Hei ZQ, Pang HY, (2009) [The comparative proteomic analysis of serum cytokine expression in acute lung injury patients in peri-operative stage of liver transplantation]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 21: 74-78.
5. Jiang A, Liu C, Liu F, Song YL, Li QY, et al. (2012) Liver cold preservation induce lung surfactant changes and acute lung injury in rat liver transplantation. World J Gastroenterol 18: 323-330.
6. Gan X, Liu D, Huang P, Gao W, Chen X, et al. (2012) Mast-cell-releasing tryptase triggers acute lung injury induced by small intestinal ischemia-reperfusion by activating PAR-2 in rats. Inflammation 35: 1144-1153.
7. He X, Han B, Mura M, Li L, Cypel M, et al. (2008) Anti-human tissue factor antibody ameliorated intestinal ischemia reperfusion-induced acute lung injury in human tissue factor knock-in mice. PLoS One 3: e1527.
8. Huang P, Liu D, Gan X, Zhang R, Gao W, et al. (2012) Mast cells activation contribute to small intestinal ischemia reperfusion induced acute lung injury in rats. Injury 43: 1250-1256.
9. Menoret A, Kumar S, Vella AT, (2012) Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury. PLoS One 7: e40184.
10. O'Mahony DS, Glavan BJ, Holden TD, Fong C, Black RA, et al. (2012) Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study. PLoS One 7: e51104.
11. Chi X, Zhang A, Luo G, Xia H, Zhu G, et al. (2013) Knockdown of myeloid differentiation protein-2 reduces acute lung injury following orthotopic autologous liver transplantation in a rat model. Pulm Pharmacol Ther 26: 380-387.
12. Rodewald HR, Dessing M, Dvorak AM, Galli SJ, (1996) Identification of a committed precursor for the mast cell lineage. Science 271: 818-822.
13. Sur R, Cavender D, Malaviya R, (2007) Different approaches to study mast cell functions. Int Immunopharmacol 7: 555-567.
14. Caughey GH, (2007) Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 217: 141-154.
15. Vieira SM, Lemos HP, Grespan R, Napimoga MH, Dal-Secco D, et al. (2009) A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5. Br J Pharmacol 158: 779-789.
16. Hei ZQ, Gan XL, Huang PJ, Wei J, Shen N, et al. (2008) Influence of Ketotifen, Cromolyn Sodium, and Compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats. BMC Gastroenterol 8: 42.
17. Ruh J, Vogel F, Schmidt E, (2000) In vivo assessment of villous microcirculation in the rat small intestine in indomethacin-induced inflammation: role of mast-cell stabilizer Ketotifen. Acta Physiol Scand 170: 137-143.
18. Santone DJ, Shahani R, Rubin BB, Romaschin AD, Lindsay TF, (2008) Mast cell stabilization improves cardiac contractile function following hemorrhagic shock and resuscitation. Am J Physiol Heart Circ Physiol 294: H2456-2464.
19. Zhao HF, Zhang GW, Zhou J, Lin JH, Cui ZL, et al. (2009) Biliary tract injury caused by different relative warm ischemia time in liver transplantation in rats. Hepatobiliary Pancreat Dis Int 8: 247-254.
20. Hofbauer B, Saluja AK, Bhatia M, Frossard JL, Lee HS, et al. (1998) Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology 115: 1238-1247.
21. Webster JD, Kiupel M, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V, (2004) The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 41: 371-377.
22. Webster JD, Kiupel M, Yuzbasiyan-Gurkan V, (2006) Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors. BMC Cancer 6: 85.
23. Li GS, Ye QF, Xia SS, Chen ZS, Zeng FJ, et al. (2002) Acute respiratory distress syndrome after liver transplantation: etiology, prevention and management. Hepatobiliary Pancreat Dis Int 1: 330-334.
24. Arieff AI, (1999) Fatal postoperative pulmonary edema: pathogenesis and literature review. Chest 115: 1371-1377.
25. Ortis F, Pirot P, Naamane N, Kreins AY, Rasschaert J, et al. (2008) Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells. Diabetologia 51: 1213-1225.
26. Glasgow SC, Ramachandran S, Blackwell TS, Mohanakumar T, Chapman WC, (2007) Interleukin-1beta is the primary initiator of pulmonary inflammation following liver injury in mice. Am J Physiol Lung Cell Mol Physiol 293: L491-496.
27. Glasgow SC, Ramachandran S, Csontos KA, Jia J, Mohanakumar T, et al. (2005) Interleukin-1beta is prominent in the early pulmonary inflammatory response after hepatic injury. Surgery 138: 64-70.
28. Tran TA, Nguyen AD, Chang J, Goldberg MS, Lee JK, et al. (2011) Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B. PLoS One. 6: e23660.
29. Parkash J, (2011) Tumor necrosis factor-alpha induces transcriptional activation of nuclear factor-kappaB in insulin-producing beta-cells. Exp Ther Med 2: 21-26.
30. Gurkan OU, He C, Zielinski R, Rabb H, King LS, et al. (2011) Interleukin-6 mediates pulmonary vascular permeability in a two-hit model of ventilator-associated lung injury. Exp Lung Res 37: 575-584.
31. Kox M, Vaneker M, van der Hoeven JG, Scheffer GJ, Hoedemaekers CW, et al. (2012) Effects of vagus nerve stimulation and vagotomy on systemic and pulmonary inflammation in a two-hit model in rats. PLoS One 7: e34431.
32. Chevrel G, Granet C, Miossec P, (2005) Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis 64: 1257-1262.
33. Bernstein IL, Siegel SC, Brandon ML, Brown EB, Evans RR, et al. (1972) A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy. J Allergy Clin Immunol 50: 235-245.
34. Shapiro GG, Konig P, (1985) Cromolyn sodium: a review. Pharmacotherapy 5: 156-170.
35. Mazurek N, Bashkin P, Petrank A, Pecht I, (1983) Basophil variants with impaired cromoglycate binding do not respond to an immunological degranulation stimulus. Nature 303: 528-530.
36. Mazurek N, Berger G, Pecht I, (1980) A binding site on mast cells and basophils for the anti-allergic drug cromolyn. Nature 286: 722-723.
37. Craps L, (1983) Prophylaxis of asthma with ketotifen in children and adolescents: a review. Pharmatherapeutica 3: 314-326.
38. Grant SM, Goa KL, Fitton A, Sorkin EM, (1990) Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 40: 412-448.
39. Kalia N, Brown NJ, Wood RF, Pockley AG, (2005) Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury. J Gastroenterol Hepatol 20: 1032-1038.
40. Medici TC, Radielovic P, Morley J, (1989) Ketotifen in the prophylaxis of extrinsic bronchial asthma. A multicenter controlled double-blind study with a modified-release formulation. Chest 96: 1252-1257.
41. Monie RD, Smith AP, Leopold D, Anderson G, Davies BH, et al. (1982) A double-blind clinical trial of ketotifen and disodium cromoglycate in bronchial asthma. Br J Dis Chest 76: 383-389.
42. Mylona-Karayanni C, Hadziargurou D, Liapi-Adamidou G, Anagnostakis I, Sinaniotis C, et al. (1990) Effect of ketotifen on childhood asthma: a double-blind study. J Asthma 27: 87-93.
43. Romanski B, Pawlik-Miskiewicz K, Wilewska-Klubo T, (1983) Clinical studies on the protective effects of Ketotifen and Intal in atopic asthmatic patients. Allergol Immunopathol (Madr) 11: 34-39.
44. Okayama Y, Tkaczyk C, Metcalfe DD, Gilfillan AM, (2003) Comparison of Fc epsilon RI- and Fc gamma RI-mediated degranulation and TNF-alpha synthesis in human mast cells: selective utilization of phosphatidylinositol-3-kinase for Fc gamma RI-induced degranulation. Eur J Immunol 33: 1450-1459.
45. Venkatesha RT, Berla Thangam E, Zaidi AK, Ali H, (2005) Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol Immunol 42: 581-587.
46. Woolhiser MR, Okayama Y, Gilfillan AM, Metcalfe DD, (2001) IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma. Eur J Immunol 31: 3298-3307.
47. Yang H, Wei J, Zhang H, Lin L, Zhang W, et al. (2009) Upregulation of Toll-like receptor (TLR) expression and release of cytokines from P815 mast cells by GM-CSF. BMC Cell Biol 10: 37.
48. Reuter S, Stassen M, Taube C, (2010) Mast cells in allergic asthma and beyond. Yonsei Med J 51: 797-807.
49. Kajiwara N, Sasaki T, Bradding P, Cruse G, Sagara H, et al. (2010) Activation of human mast cells through the platelet-activating factor receptor. J Allergy Clin Immunol 125: 1137-1145 e1136.
50. Jin E, Fujiwara M, Pan X, Ghazizadeh M, Arai S, et al. (2003) Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas. Cancer 97: 703-713.
51. Sokolova E, Reiser G, (2007) A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors. Pharmacol Ther 115: 70-83.
52. Takizawa T, Tamiya M, Hara T, Matsumoto J, Saito N, et al. (2005) Abrogation of bronchial eosinophilic inflammation and attenuated eotaxin content in protease-activated receptor 2-deficient mice. J Pharmacol Sci 98: 99-102.
53. Su X, Camerer E, Hamilton JR, Coughlin SR, Matthay MA, (2005) Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J Immunol 175: 2598-2605.
54. Kuehn HS, Radinger M, Gilfillan AM (2010) Measuring mast cell mediator release. Curr Protoc Immunol Chapter 7: Unit7 38.
55. Henderson WR Jr, Lewis DB, Albert RK, Zhang Y, Lamm WJ, et al. (1996) The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 184: 1483-1494.
56. Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM, (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40: 643-672.
57. Sirois MG, de Lima WT, de Brum Fernandes AJ, Johnson RJ, Plante GE, et al. (1994) Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes. Br J Pharmacol 111: 1111-1116.
58. Zimmerman GA, McIntyre TM, (2004) PAF, ceramide and pulmonary edema: alveolar flooding and a flood of questions. Trends Mol Med 10: 245-248.
59. Walcher F, Marzi I, Fischer R, Bauer M, Larsen R, (1996) Platelet-activating factor is involved in the regulation of pathological leukocyte adhesion after liver transplantation. J Surg Res 61: 244-249.
60. Shiraishi Y, Asano K, Nakajima T, Oguma T, Suzuki Y, et al. (2005) Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharmacol Exp Ther 312: 954-960.